Head-to-head
Gala GLP-1 vs Luvo Health
Compared on both medications across the eight dimensions this database records. They differ on 5 of those eight. Gala GLP-1 is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Gala GLP-1 is $179 a month all-in for tirzepatide; Luvo Health is $339. Over twelve months that is $2,148 against $3,492. Value Scores are 91.6 and 50.4 out of 100.
Tirzepatide
Plan pages: Gala GLP-1 plans · Luvo Health plans
At 10 mg/week, Gala GLP-1 is $179 a month all-in and Luvo Health is $339 — $160 apart, or $1,920 across a year. Over twelve months the totals are $2,148 (billed monthly) and $3,492 (prepaid term).
Gala GLP-1 charges a flat $179 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
Luvo Health charges a flat $339 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.
| Dose | Gala GLP-1 | Rank | Luvo Health | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $179 | 4/31 | $339 | 22/31 | Gala GLP-1 by $160 |
| 5 mg | $179 | 2/17 | — | — | only Gala GLP-1 publishes |
| 7.5 mg | $179 | 2/17 | — | — | only Gala GLP-1 publishes |
| 10 mg | $179 | 2/27 | $339 | 16/27 | Gala GLP-1 by $160 |
| 12.5 mg | $179 | 2/17 | — | — | only Gala GLP-1 publishes |
| 15 mg | $179 | 2/17 | — | — | only Gala GLP-1 publishes |
Gala GLP-1 is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 27 programs this database can rank on tirzepatide, Gala GLP-1 sits 3 of 27 on all-in monthly cost and Luvo Health sits 14. There are 10 other programs priced between them. The field median is $339 and the floor is $169, so both sit below the median. Gala GLP-1 is $10 above the cheapest tirzepatide program on record. Luvo Health is $170 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — Gala GLP-1 undercuts it by $270, Luvo Health by $110. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Gala GLP-1 | Luvo Health | Cheaper |
|---|---|---|---|
| Month to month | $179 | $339 | Gala GLP-1 by $160 |
| 3-month term | $199 | — | only Gala GLP-1 publishes this term |
| 12-month term | — | $291 | only Luvo Health publishes this term |
| Settled dose | Gala GLP-1 | Luvo Health | Difference |
|---|---|---|---|
| 2.5 mg | $2,148 | $4,068 | $1,920 apart |
| 5 mg | $2,148 | — | one side unpriced |
| 7.5 mg | $2,148 | — | one side unpriced |
| 10 mg | $2,148 | $4,068 | $1,920 apart |
| 12.5 mg | $2,148 | — | one side unpriced |
| 15 mg | $2,148 | — | one side unpriced |
Gala GLP-1 publishes no rate for 6-month term, 12-month term; Luvo Health publishes none for 3-month term, 6-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $2,148 on Gala GLP-1 and $4,068 on Luvo Health. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
That calculation is partial: Luvo Health publishes no price at 2 of them, so the maintenance rate stands in for the missing steps rather than a number the company has stated.
Value Scores are 91.6 for Gala GLP-1 and 50.4 for Luvo Health, against a tirzepatide category floor of $169. Gala GLP-1 leads by 41.2 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Gala GLP-1 | 66.1 | 10.5 | 10 | 5 | 91.6 |
| Luvo Health | 34.9 | 10.5 | 0 | 5 | 50.4 |
Semaglutide
Plan pages: Gala GLP-1 plans · Luvo Health plans
At 2.4 mg/week, Gala GLP-1 is $179 a month all-in and Luvo Health is $249 — $70 apart, or $840 across a year. Over twelve months the totals are $2,148 (billed monthly) and $2,328 (prepaid term).
Gala GLP-1 charges a flat $179 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Luvo Health charges a flat $249 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.
Gala GLP-1 is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Value Scores are 75.9 for Gala GLP-1 and 51.8 for Luvo Health, against a semaglutide category floor of $129. Gala GLP-1 leads by 24.1 points, driven mostly by price.
Where the two programs differ
All-in monthly
Gala GLP-1 is cheaper month to month — $179 against $339, a gap of $160 every month, or $1,920 across a year if both rates hold.
Cancellation terms
Cancellation differs: Gala GLP-1 states Per provider terms, while Luvo Health states No-commitment 4-week option available; confirm annual plan refund terms. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
Gala GLP-1 asks for 3-month plan or standard monthly; confirm exact terms at enrollment; Luvo Health asks for 52-week (annual) plan billed as lump-sum ($3,497 tirz / $2,327 sema) OR 4-week rolling ($339/$249 per term, no commitment). This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
Gala GLP-1 charges one price at every dose; Luvo Health prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Twelve-month cost
Over twelve months the totals are $2,148 for Gala GLP-1 and $3,492 for Luvo Health. Gala GLP-1 is lower by $1,344 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Evidence status
Both figures carry the same evidence status, reported: sourced from dated third-party reporting; first-party capture pending. Neither is stronger than the other on provenance.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
Gala GLP-1 Official site
Gala GLP-1 is an all-50-state compounded GLP-1 service offering a range of pricing by product tier, including a microdosing option. Its standard all-dose rate is $179/mo (tirz) and $179/mo (sema) with a microdosing tier starting at $149.
It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacies (not named publicly), so who actually makes the medication cannot be independently verified; commitment terms are 3-month plan or standard monthly; confirm exact terms at enrollment; cancellation is Per provider terms; availability is stated as All 50 states (per provider claim; confirm at intake).
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, capture 2026-07-14
Watch: Gala lists a range rather than one fixed price: the hero says $179/mo 'all doses', the FAQ says $199/mo 'with a 3-month plan', and $149/mo is listed for microdosing. This makes 'all-in maintenance' ambiguous; we rank on the $179 standard figure with a note. Exact ongoing rate must be confirmed at enrollment. Reported status from RangeYourself 2026-07-14.
Luvo Health Official site
Luvo Health publishes an openly available price ladder for compounded GLP-1s — semaglutide and tirzepatide — alongside longevity peptides. It names four dispensing pharmacy partners. Its 52-week (annual) plan offers the lowest per-month-equivalent rate; no-commitment 4-week terms cost materially more.
It does not publicly name its compounding pharmacy; the record shows Four named dispensing compounding pharmacies (specific names per provider materials), so who actually makes the medication cannot be independently verified; commitment terms are 52-week (annual) plan billed as lump-sum ($3,497 tirz / $2,327 sema) OR 4-week rolling ($339/$249 per term, no commitment); cancellation is No-commitment 4-week option available; confirm annual plan refund terms; availability is stated as All 50 states claimed; some services may not be available in all states per Luvo terms.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, Luvo published $3,497 term total, verified 2026-08-08
Watch: Luvo publishes plan-TERM totals in weeks, not monthly prices; our monthly figures divide the term total by 12 calendar months, but 52 weeks = 13 four-week cycles, so the true per-cycle cost is slightly different. Luvo makes no third-party testing claim and its own evaluation does not include lab testing. Geographic availability is a qualified all-50-states claim. Reported status — RangeYourself verified 2026-08-08.
What neither record tells you
Gala GLP-1 does not publish
- no published twelve-month tirzepatide rate
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says All 50 states (per provider claim; confirm at intake)
- no specific cancellation or refund terms
Luvo Health does not publish
- no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
- no semaglutide price at 0.5, 1, 1.7 mg per week
- no named compounding pharmacy
Ask Gala GLP-1 and Luvo Health for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. Gala GLP-1, Luvo Health carry a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Prepaid terms move the annual figures. Luvo Health publishes a twelve-month rate of $291 a month against $339 month-to-month. Read those next to the cancellation terms, not the monthly rate.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, Gala GLP-1 Official site wins this matchup. If you expect to titrate to the top of the ladder, gala glp-1's flat pricing is worth more than the headline gap suggests.
Both figures should be checked at the provider's own checkout before you pay. Gala GLP-1's tirzepatide price is reported as of 2026-07-14; Luvo Health's is reported as of 2026-08-08.
Questions
Is Gala GLP-1 or Luvo Health cheaper for tirzepatide?
Gala GLP-1 is cheaper on all-in monthly cost at 10 mg/week: $179 against $339, a difference of $160 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Gala GLP-1 versus Luvo Health?
Gala GLP-1 works out to $2,148 across twelve months and Luvo Health to $3,492, on the plan terms each publishes.
Does Gala GLP-1 or Luvo Health raise the price as the dose goes up?
Gala GLP-1: no, it charges one flat rate at every dose. Luvo Health: yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Gala GLP-1 and Luvo Health differ?
5 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Gala GLP-1 and Luvo Health names its pharmacy?
Neither. Gala GLP-1 records Partner 503A pharmacies (not named publicly) and Luvo Health records Four named dispensing compounding pharmacies (specific names per provider materials). Without a named pharmacy, neither program's licensing or inspection history can be checked before you order.
How well evidenced are the Gala GLP-1 and Luvo Health prices?
Gala GLP-1's tirzepatide figure is reported — sourced from dated third-party reporting; first-party capture pending — captured 2026-07-14. Luvo Health's is reported, captured 2026-08-08. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Which is cheaper for semaglutide?
Gala GLP-1, at $179 a month all-in against $249 at 2.4 mg/week. The two programs do not necessarily lead on both medications.
Official sources: Gala GLP-1 official site · Luvo Health official site. Compounded tirzepatide and semaglutide are not FDA-approved products.